| Sample | Title | Value | Rank |
|---|
| GSM132917 | SKI-DLCL cells_untreated_24h_1rpt | 549.5 | 90 |
| GSM132918 | SKI-DLCL cells_untreated_24h_2rpt | 568.1 | 91 |
| GSM132920 | SKI-DLCL cells_untreated_24h_rpt3 | 597.5 | 91 |
| GSM132941 | SKI-DLCL cells_Aplidin 3nM_24h_rpt1 | 569.8 | 91 |
| GSM132944 | SKI-DLCL cells_Aplidin 3.0nM_24h_rpt2 | 584 | 91 |
| GSM132947 | SKI-DLCL cells_Aplidin treated 3nM_24h_rpt3 | 543.1 | 90 |
| GSM132949 | SKI-DLCL cells_AraC 20nM_24h_rpt1 | 640.9 | 92 |
| GSM132950 | SKI-DLCL cells_AraC 20nM_24h_rpt2 | 605.3 | 91 |
| GSM132953 | SKI-DLCL cells_AraC 20nM_24h_rpt3 | 620.7 | 91 |
| GSM132955 | SKI-DLCL cells_Aplidin 1.5nM AraC 5nM_24h_rpt1 | 553.8 | 90 |
| GSM132956 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5nM_24h_rpt2 | 495.9 | 89 |
| GSM132960 | SKI-DLCL cells_Aplidin 1.5 nM AraC 5.0 nM_24h_rpt3 | 563.2 | 91 |
| GSM132760 | SKI-DLCL_tumor_untreated animals | 437.5 | 89 |
| GSM132916 | SKI-DLCL_tumor_animals treated with 1mg/kg Aplidin_50mg/kg AraC | 396.6 | 88 |